Abstract
Erectile dysfunction (ED) can negatively impact the quality of life among men, and increasingly affects all age strata. This has led to an explosion of health information on ED both for patients and doctors, which may cause potentially harmful effects when misused or abused. Therefore, the necessity of developing a standardized, appropriate guideline for the diagnosis and management of ED is increasing. In this review, the author describes risk factors, diagnosis and treatment guidelines for ED, which can be usefully applied in clinical practice.
| Original language | English |
|---|---|
| Pages (from-to) | 443-451 |
| Number of pages | 9 |
| Journal | Journal of the Korean Medical Association |
| Volume | 58 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - 2015 Jan 1 |
Fingerprint
Keywords
- Erectile dysfunction
- Guideline
- Phosphodiesterase 5 inhibitors
- Risk factors
ASJC Scopus subject areas
- Medicine(all)
Cite this
The risk factors, diagnosis and treatment guideline of erectile dysfunction. / Moon, Du Geon.
In: Journal of the Korean Medical Association, Vol. 58, No. 5, 01.01.2015, p. 443-451.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - The risk factors, diagnosis and treatment guideline of erectile dysfunction
AU - Moon, Du Geon
PY - 2015/1/1
Y1 - 2015/1/1
N2 - Erectile dysfunction (ED) can negatively impact the quality of life among men, and increasingly affects all age strata. This has led to an explosion of health information on ED both for patients and doctors, which may cause potentially harmful effects when misused or abused. Therefore, the necessity of developing a standardized, appropriate guideline for the diagnosis and management of ED is increasing. In this review, the author describes risk factors, diagnosis and treatment guidelines for ED, which can be usefully applied in clinical practice.
AB - Erectile dysfunction (ED) can negatively impact the quality of life among men, and increasingly affects all age strata. This has led to an explosion of health information on ED both for patients and doctors, which may cause potentially harmful effects when misused or abused. Therefore, the necessity of developing a standardized, appropriate guideline for the diagnosis and management of ED is increasing. In this review, the author describes risk factors, diagnosis and treatment guidelines for ED, which can be usefully applied in clinical practice.
KW - Erectile dysfunction
KW - Guideline
KW - Phosphodiesterase 5 inhibitors
KW - Risk factors
UR - http://www.scopus.com/inward/record.url?scp=84982083216&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84982083216&partnerID=8YFLogxK
U2 - 10.5124/jkma.2015.58.5.443
DO - 10.5124/jkma.2015.58.5.443
M3 - Article
AN - SCOPUS:84982083216
VL - 58
SP - 443
EP - 451
JO - Journal of the Korean Medical Association
JF - Journal of the Korean Medical Association
SN - 1975-8456
IS - 5
ER -